IX BIOPHARMA LTD.

Last Updated: 14 Nov 2025

IX BIOPHARMA LTD. is ACRA -registered entity that has been operating for 21 years 7 months in Singapore since its incorporation in 2004.

Officially, IX BIOPHARMA LTD. is registered as Public Company Limited By Shares with its address 20 COLLYER QUAY, #11-07, 20 COLLYER QUAY, Singapore 049319.

Country of registration	Singapore
Registration number	200405621W
Local SIC	72106: Research and experimental development on environment and clean technologies
Incorporation date	8 May 2004
Company age	21 years 7 months
Official entity type	Public Company Limited By Shares
No. of officers	20

Contact

Address:

20 COLLYER QUAY, #11-07, 20 COLLYER QUAY, Singapore 049319

Phone number:

Access Key Decision Makers

This is the legal entity page of IX BIOPHARMA LTD.. To access company info, company size, news , key makers’ emails, visit the profile pages above.

The largest company and people database for SEA & ANZ

Associated business (1)

IX BIOPHARMA
Singapore
View More
therapies for diseases of the central nervous system
pain management
novel drug delivery systems
patented sublingual drug delivery technology
Pharmaceuticals
Manufacturing
iX Biopharma is a listed, specialty pharmaceutical and nutraceutical company focused on developing and commercializing innovative therapies for diseases of the central nervous system via novel, patent-protected sublingual formulations. Our product pipeline includes Wafermine (ketamine wafer) and BnoX (buprenorphine wafer) for pain management, as well as Wafesil and Silcap for erectile dysfunction. Additionally, we have developed Xativa, the world's first freeze-dried sublingual medicinal cannabis wafer. Our nutraceuticals division, Entity Health Limited, is dedicated to the development and commercialization of nutraceutical products.

This is the legal entity page of IX BIOPHARMA LTD.. To access company info, company size, news, key maker's emails, visit the profile pages above.

Financials

Fiscal/Budgeting Period	April - June
Auditor	PRICEWATERHOUSECOOPERS LLP
Revenue	11m - 25m
Financial period end date	30 Jun 2022
Share Capital - Ordinary shares	SGD 95,411,168

Last updated: 14 Nov 2025

* This information is provided to the best of our research ability and we make no warranties for any inaccuracies or omissions.

Discover More Companies

Lookalike companies

* This profile contains information from ACRA Information on Corporate Entities from Accounting and Corporate Regulatory Authority which is made available under the terms of the Singapore Open Data Licence version 1.0. Information and datasets on our website are provided on an “as is” and “as available” basis. This website makes no representations or warranties concerning the datasets, including but not limited to any representation or warranty as to the accuracy, completeness, reliability, continued availability, timeliness, non-infringement, title, quality, or fitness for any particular purpose of the datasets to the fullest extent permitted by the law.

Frequently Asked Questions (FAQ)

What is the address of IX BIOPHARMA LTD.?
Where is IX BIOPHARMA LTD.'s headquarter?
What is IX BIOPHARMA LTD.'s contact number?
What IX BIOPHARMA LTD.'s spending power?
Does IX BIOPHARMA LTD. have a presence in the domain it operates in?